首页 › 基金 › Eversept Partners, LP › CRVS

Eversept Partners, LP 对 CRVS 的持仓历史

CORVUS PHARMACEUTICALS I · 医疗保健

Eversept Partners, LP 在 Q2 2026 的 13F 申报中披露持有 CRVS(CORVUS PHARMACEUTICALS I)747,994 股,市值约 US$11.2M,约占其申报组合的 0.58%,在其申报持仓中市值排名第 42 位。 Eversept Partners, LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)747.99K 股
申报持仓市值$11.18M
组合权重0.58%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Eversept Partners, LP 对 CRVS 的持仓演变

Eversept Partners, LP 于 Q2 2026 首次披露 CRVS 持仓:747,994 股(约 US$11.2M)。

逐季持仓明细

季度股数金额变化
Q2 2026 747.99K $11.18M 新进

关于 CRVS 与 13F 数据

CRVS(CORVUS PHARMACEUTICALS I)属于医疗保健行业。我们追踪的基金中还有 72 只申报持有 CRVS,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), Vivo Capital, LLC (US$41.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CRVS 的基金

查看 CRVS 的全部基金持有人 →

常见问题

How long has Eversept Partners, LP held CRVS?

Eversept Partners, LP has disclosed CRVS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Eversept Partners, LP's current position in CRVS?

As of Q2 2026, Eversept Partners, LP holds 747.99K shares of CRVS (CORVUS PHARMACEUTICALS I), valued at $11.18M, representing 0.58% of its reported portfolio and ranking #42.

Has Eversept Partners, LP been buying or selling CRVS?

In the latest 13F filing (Q2 2026), Eversept Partners, LP newly opened its position in CRVS.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Vivo Capital, LLC, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.